What changed
$JD — BUY 📊 | 6 MONTHS THESIS
🎯 latest | Rev $262.7B | EPS $5.12 vs $3.64 🟢
💡 Consensus expected muted earnings amid China macro and competition fears; actual EPS beat by 41%, revealing stronger-than-expected operating leverage and share stability. The variant view is that JD can sustain mid-teens earnings growth, while the market still prices near-recessionary scenarios.
📉 Reward/risk: 2.1:1
🏢 Business Quality: 7/10
📊 Valuation: fair — trailing P/E of 19.8x (based on converted EPS per ADS) is above historical troughs, but forward P/E of ~14x on upward-revised estimates is...
🔮 Catalyst: Post-earnings analyst upgrades and upward estimate revisions
💰 Entry: $28.56, stop $26.0, target $34.0
📊 Our read: BUY. Full analysis →
https://stockduty.xyz/s/JD0614